Neuropsychiatric manifestations in systemic sclerosis;Atteintes neuropsychiatriques au cours de la sclérodermie systémique

Presse Medicale

Volumn 39, Issue 5, 2010, Pages 539-547

  Launay, David ^a   Baubet, Thierry ^b   Cottencin, Olivier ^c   Bérezné, Alice ^d   Zéphir, Hélène ^c   Morell Dubois, Sandrine ^a   Pruvo, Jean Pierre ^c   Guillevin, Loïc ^d   Hatron, Pierre Yves ^a   Hachulla, Eric ^a   Mouthon, Luc ^d  

^a UNIV LILLE   (France)

^b AVICENNE HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CALCIFICATION; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LEUKOARAIOSIS; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PREVALENCE; SCLERODERMA; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; WHITE MATTER;

EID: 77952742583     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.10.004     Document Type: Short Survey

References (65)

1. Servettaz A., Agard C., Tamby M.C., Guilpain P., Guillevin L., Mouthon L. Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes. Presse Med 2006, 35:1903-1915.
2. Steen V.D., Medsger T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000, 43:2437-2444.
3. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La Montagna G., et al. Systemic sclerosis. Demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine 2002, 81:139-153.
4. Hachulla E., Launay D., Pruvo J.P., Leys D. Manifestations neurologiques de la sclérodermie systémique. Atteintes neurologiques au cours des maladies systémiques 2003, Flammarion Médecine Sciences, Paris.
5. Heron E., Hernigou A., Fornes P., Chatellier G., Emmerich J., Fiessinger J.N. Central nervous system involvement in scleroderma. Ann Med Interne (Paris) 2002, 153:179-182.
6. Steven J. Case of scleroderma with pronounced hemiatrophy of the face, body and extremities-death from ovarian tumor-account on the postmortem examination: a sequel. Glasgow Med J 1898, 50:401-422.
7. Sardanelli F., Iozzelli A., Cotticelli B., Losacco C., Cutolo M., Sulli A., et al. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005, 64:777-779.
8. Bertinotti L., Mortilla M., Conforti M.L., Colangelo N., Nacci F., Del Rosso A., et al. Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis. J Rheumatol 2006, 33:546-551.
9. Thombs B., Taillefer S., Hudson M., Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Care Res 2007, 57:1089-1097.
10. Baubet T., Brunet M., Garcia de la Pena-Lefebvre, Taieb O., Moro M.R., Guillevin L., et al. Les manifestations psychiatriques de la sclérodermie systémique. Ann Med Interne (Paris) 2002, 153:237-241.
11. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002, 53:83-107.
12. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
13. Jimenez-Moreno J., Selva-O'Callaghan A., Rovira-Canellas A., Solans-Laque R., Len O., Fonollosa-Pla V., et al. Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 1998, 37:587-589.
14. Pathak R., Gabor A.J. Scleroderma and central nervous system vasculitis. Stroke 1991, 22:410-413.
15. Heron E., Fornes P., Rance A., Emmerich J., Bayle O., Fiessinger J.N. Brain involvement in scleroderma: two autopsy cases. Stroke 1998, 29:719-721.
16. Heron E., Hernigou A., Chatellier G., Fornes P., Emmerich J., Fiessinger J.N. Intracerebral calcification in systemic sclerosis. Stroke 1999, 30:2183-2185.
17. Terrier B., Charbonneau F., Touzé E., Berezne A., Pagnoux C., Silvera S. Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis. Rheumatol. 2009, 36(7):1486-1494.
18. Smith E.A., Schumacher H.R., Silver R.M. Symptomatic spinal calcinosis in systemic sclerosis (scleroderma). Arthritis Rheum 1997, 40:1892-1895.
19. Schweitzer M.E., Cervilla V., Manaster B.J., Gerharter J., Dalinka M., Peck W.W., et al. Cervical paraspinal calcification in collagen vascular diseases. AJR Am J Roentgenol 1991, 157:523-525.
20. Petrocelli A.R., Basset L.W., Mirra J., Gold R.H., Brahn E. Scleroderma: dystrophic calcification with spinal cord compression. J Rheumatol 1988, 15:1733-1735.
21. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
22. Blennow K., Wallin A., Uhlemann C., Gottfries C.G. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991, 83:187-193.
23. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987, 149:351-356.
24. Cutolo M., Nobili F., Sulli A., Pizzorni C., Briata M., Faelli F., et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 2000, 39:1366-1373.
25. Nobili F., Cutolo M., Sulli A., Castaldi A., Sardanelli F., Accardo S., et al. Impaired quantitative cerebral blood flow in scleroderma patients. J Neurol Sci 1997, 152:63-71.
26. Loessner A., Alavi A., Lewandrowski K.U., Mozley D., Souder E., Gur R.E. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995, 36:1141-1149.
27. Sabri O., Hellwig D., Schreckenberger M., Cremerius U., Schneider R., Kaiser H.J., et al. Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy. J Nucl Med 1998, 39:147-154.
28. Signorini M., Paulesu E., Friston K., Perani D., Colleluori A., Lucignani G., et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage 1999, 9:63-80.
29. Jeong Y., Cho S.S., PArk J.M., Kang S.J., Lee J.S., KAng E., et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 2005, 46:233-239.
30. Peterson P.L., Axford J.S., Isenberg D. Imaging in CNS lupus. Best Pract Res Clin Rheumatol 2005, 19:727-739.
31. Weiner S.M., Otte A., Schumacher M., Klein R., Gutfleisch J., Brink I., et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000, 59:377-385.
32. Sofat N., Malik O., Higgens C.S. Neurological involvement in patients with rheumatic disease. QJM 2006, 99:69-79.
33. Roca R.P., Wigley F.M., White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 1996, 39:1035-1040.
34. Straszecka J., Kucharz E.J., Jonderko G., Kotulska A., Bednarczyk-Kaluzny M., Brzezinska-Wcislo L., et al. Depression and anxiety in patients with systemic sclerosis. Clin Rheumatol 1996, 15:621.
35. Angelopoulos N.V., Drosos A.A., Moutsopoulos H.M. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001, 70:145-150.
36. Haythornthwaite J.A., Heinberg L.J., McGuire L. Psychologic factors in scleroderma. Rheum Dis Clin North Am 2003, 29:427-439.
37. Matsuura E., Ohta A., Kanegae F., Haruda Y., Ushiyama O., Koarada S., et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 2003, 30:1782-1787.
38. Legendre C., Allanore Y., Ferrand I., Kahan A. Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 2005, 72:408-411.
39. Benrud-Larson L.M., Haythornthwaite J.A., Heinberg L.J., Boling C., Reed J., White B., et al. The impact of pain and symptoms of depression in scleroderma. Pain 2002, 95:267-275.
40. Wise T.N., Ginzler E.M. Scleroderma cerebritis, an unusual manifestation of progressive systemic sclerosis. Dis Nerv Syst 1975, 36:60-62.
41. Hyphantis T.N., Tsifetaki N., Pappa C., Voulgari P.V., Siafaka V., Bai M., et al. Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 2007, 62:47-56.
42. Beretta L., Astori S., Ferrario E., Caronni M., Raimondi M., Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo 2006, 58:219-225.
43. Nietert P.J., Mitchell H.C., Bolster M.B., Curran M.Y., Tilley B.C., Silver R.M. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005, 32:51-57.
44. Richards H.L., Herrick A.L., Griffin K., Gwilliam P.D., Loukes J., Fortune D.G. Systemic sclerosis: patients' perceptions of their condition. Arthritis Rheum 2003, 49:689-696.
45. Baubet T., Taieb O., Mehallel S., Moroni C., Belin C., Bricou O., et al. Suicide risk, affective and anxiety disorders in patients with systemic sclerosis. (Abstract). Arthritis Rheum 2004.
46. Thombs B.D., Hudson M., Taillefer S., Baron M. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 2008, 59:504-509.
47. Ohayon M.M., Priest R.G., Guilleminault C., Caulet M. The prevalence of depressive disorders in the United Kingdom. Biol Psychiatry 1999, 45:300-307.
48. Dickens C., McGowan L., Clark-Carter D., Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002, 64:52-60.
49. Omdal R., Waterloo K., Koldingsnes W., Husby G., Mellgren S.I. Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol 2003, 30:283-287.
50. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006, 21:30-38.
51. Shaban M.C., Fosbury J., Kerr D., Cavan D.A. The prevalence of depression and anxiety in adults with Type 1 diabetes. Diabet Med 2006, 23:1391-1484.
52. Henkel V., Mergl R., Coyne J.C., Kohnen R., Moller H.J., Hegern U. Screening for depression in primary care: will one or two items suffice?. Eur Arch Psychiatry Clin NeuroSci 2004, 254:215-223.
53. Druss B., Pincus H. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med 2000, 160:1522-1526.
54. Ritchie K., Artero S., Beluche I., Ancelin M.L., Mann A., Dupuy A.M., et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatrie 2004, 184:147-152.
55. Benrud-Larson L.M., Heinberg L.J., Boling C., Reed J., White B., Wigley F.M., et al. Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 2003, 22:130-139.
56. Herrick A.I., Richards H.L., Griffin K., Salford P.G. The psychosocial impact of systemic sclerosis. (Abstract). Arthritis Rheum 2001, 44:s327.
57. Lepine J.P., Gasquet I., Kovess V., Arbabzadeh-Bouchez S., Negre-Pages L., Nachbaur G., et al. Prévalence et comorbidité des troubles psychiatriques dans la population générale française. Encephale 2005, 31:182-194.
58. Gottwald W., Benos J. Die neurologieschen und psychiatrischen syndrome der sklerodermie. Fortsch Neurol Psychiat 1974, 42:225-263.
59. Piper W.N., Helwig B.B. Progressive systemic sclerosis, visceral manifestations in generalized scleroderma. Arch Dermatol 1955, 72:535-546.
60. Rifkin A. Depression in physically ill patients. Don't dismiss it as 'understandable'. Postgrad Med 1992, 92:147-149.
61. Lamberg L. Treating depression in medical conditions may improve quality of life. JAMA 1996, 276:847-858.
62. Dupond J.L., Humbert P., Taillard C., de Wazieres B., Vuitton D. Relation entre maladies dysimmunitaires et traits de personnalité chez la femme. Presse Med 1990, 19:2019-2022.
63. Malcarne V.L., Greenbergs H.L. Psychological adjustment to systemic sclerosis. Arthritis Care Res 1996, 9:51-59.
64. Straszecka J., Jonderko G., Kucharz E.J., Brzezinska-Wcislo L., Kotulska A., Bogdanowski T. Cognitive function in patients with systemic sclerosis. Pol Arch Med Wewn 1997, 98:213-220.
65. Moroni C., Belin C., Baubet T., Taieb O., Bricou O., Pagnoux C., et al. Cognitive impairment in systemic sclerosis. (Abstract). Arthritis Rheum 2006, 54(9s):s744.